Steady-State Pharmacokinetic Comparison of a New, Extended-Release, Once-Daily Morphine Formulation, Avinza™, and a Twice-Daily Controlled-Release Morphine Formulation in Patients with Chronic Moderate-to-Severe Pain

Russell K. Portenoy; Andréa Sciberras; Lise Eliot; Gordon Loewen; Jackie Butler; John Devane

doi:10.1016/s0885-3924(02)00382-2

Steady-State Pharmacokinetic Comparison of a New, Extended-Release, Once-Daily Morphine Formulation, Avinza™, and a Twice-Daily Controlled-Release Morphine Formulation in Patients with Chronic Moderate-to-Severe Pain

Journal of Pain and Symptom Management ◽

10.1016/s0885-3924(02)00382-2 ◽

2002 ◽

Vol 23 (4) ◽

pp. 292-300 ◽

Cited By ~ 37

Author(s):

Russell K. Portenoy ◽

Andréa Sciberras ◽

Lise Eliot ◽

Gordon Loewen ◽

Jackie Butler ◽

...

Keyword(s):

Steady State ◽

Controlled Release ◽

Severe Pain ◽

Extended Release ◽

Once Daily

Download Full-text

Repeat-dose steady-state pharmacokinetic evaluation of once-daily hydromorphone extended-release (OROS® hydromorphone ER) in patients with chronic pain

Journal of Pain Research ◽

10.2147/jpr.s33807 ◽

2012 ◽

pp. 523 ◽

Cited By ~ 7

Author(s):

Vandenbossche ◽

Richarz ◽

Richards

Keyword(s):

Chronic Pain ◽

Steady State ◽

Extended Release ◽

Repeat Dose ◽

Once Daily ◽

Pharmacokinetic Evaluation

Download Full-text

Efficacy and safety of long-term, once-daily morphine sulfate extended-release capsules in cancer patients with chronic, moderate-to-severe pain

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.8075 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 8075-8075

Author(s):

E. S. Groves ◽

S. M. Shelby ◽

L. Schlosser

Keyword(s):

Cancer Patients ◽

Severe Pain ◽

Extended Release ◽

Morphine Sulfate ◽

Efficacy And Safety ◽

Once Daily

Download Full-text

Steady-state pharmacokinetic comparison of a new, once-daily, extended-release morphine formulation (Morphelan™) and OxyContin® twice daily

Journal of Oncology Pharmacy Practice ◽

10.1191/1078155201jp075oa ◽

2001 ◽

Vol 7 (1) ◽

pp. 1-8 ◽

Cited By ~ 7

Author(s):

Lise Eliot ◽

Rita Geiser ◽

Gordon Loewen

Keyword(s):

Steady State ◽

Extended Release ◽

Once Daily

Download Full-text

Steady-state Pharmacokinetics of Lamotrigine when Converting from a Twice-daily Immediate-release to a Once-daily Extended-release Formulation in Subjects with Epilepsy (The COMPASS Study)

Epilepsia ◽

10.1111/j.1528-1167.2007.01274.x ◽

2008 ◽

Vol 49 (3) ◽

pp. 410-417 ◽

Cited By ~ 28

Author(s):

Debra J Tompson ◽

Imran Ali ◽

Ruth Oliver-Willwong ◽

Sarah Job ◽

Li Zhu ◽

...

Keyword(s):

Steady State ◽

Extended Release ◽

Immediate Release ◽

Release Formulation ◽

Once Daily ◽

Extended Release Formulation

Download Full-text

Safety and Efficacy of Once-Daily Hydromorphone Extended-Release Versus Twice-Daily Oxycodone Hydrochloride Controlled-Release in Chinese Patients With Cancer Pain: A Phase 3, Randomized, Double-Blind, Multicenter Study

Journal of Pain ◽

10.1016/j.jpain.2014.04.008 ◽

2014 ◽

Vol 15 (8) ◽

pp. 835-844 ◽

Cited By ~ 10

Author(s):

Shiying Yu ◽

Wei Shen ◽

Lu Yu ◽

Yanyan Hou ◽

John Han ◽

...

Keyword(s):

Controlled Release ◽

Cancer Pain ◽

Extended Release ◽

Chinese Patients ◽

Phase 3 ◽

Double Blind ◽

Once Daily ◽

Safety And Efficacy ◽

Patients With Cancer ◽

Oxycodone Hydrochloride

Download Full-text

Efficacy and safety of long-term, once-daily morphine sulfate extended-release capsules in cancer patients with chronic, moderate-to-severe pain

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.8075 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 8075-8075

Author(s):

E. S. Groves ◽

S. M. Shelby ◽

L. Schlosser

Keyword(s):

Cancer Patients ◽

Severe Pain ◽

Extended Release ◽

Morphine Sulfate ◽

Efficacy And Safety ◽

Once Daily

Download Full-text

Steady-State Pharmacokinetics of Once-Daily Cyclobenzaprine Extended Release: A Randomized, Double-Blind, 2-Period Crossover Study in Healthy Volunteers

Clinical Therapeutics ◽

10.1016/j.clinthera.2011.05.045 ◽

2011 ◽

Vol 33 (6) ◽

pp. 746-753 ◽

Cited By ~ 8

Author(s):

Mona Darwish ◽

Edward T. Hellriegel

Keyword(s):

Steady State ◽

Crossover Study ◽

Healthy Volunteers ◽

Extended Release ◽

Double Blind ◽

Once Daily

Download Full-text

Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation

Epilepsia ◽

10.1111/epi.12225 ◽

2013 ◽

Vol 54 (8) ◽

pp. 1444-1452 ◽

Cited By ~ 20

Author(s):

Meir Bialer ◽

Tawfeeq Shekh-Ahmad ◽

Tricia L. Braun ◽

Mark B. Halvorsen

Keyword(s):

Steady State ◽

Extended Release ◽

Immediate Release ◽

Once Daily ◽

Pharmacokinetic Evaluation

Download Full-text

Sustained Safety and Efficacy of Once-Daily Hydromorphone Extended-Release (OROS®hydromorphone ER) Compared with Twice-Daily Oxycodone Controlled-Release Over 52 Weeks in Patients with Moderate to Severe Chronic Noncancer Pain

Pain Practice ◽

10.1111/j.1533-2500.2012.00553.x ◽

2012 ◽

Vol 13 (1) ◽

pp. 30-40 ◽

Cited By ~ 9

Author(s):

Ute Richarz ◽

Sandra Waechter ◽

Rainer Sabatowski ◽

Leszek Szczepanski ◽

Heinrich Binsfeld

Keyword(s):

Controlled Release ◽

Extended Release ◽

Chronic Noncancer Pain ◽

Once Daily ◽

Safety And Efficacy ◽

Noncancer Pain

Download Full-text

P4-403: Extended-release (ER) memantine capsule (28 mg, once daily): A multiple-dose, open-label study evaluating steady-state pharmacokinetics in healthy volunteers

Alzheimer s & Dementia ◽

10.1016/j.jalz.2008.05.2474 ◽

2008 ◽

Vol 4 ◽

pp. T792-T793

Author(s):

Antonia Periclou ◽

Yiqun Hu

Keyword(s):

Steady State ◽

Healthy Volunteers ◽

Multiple Dose ◽

Extended Release ◽

Open Label ◽

Once Daily ◽

Open Label Study ◽

Label Study

Download Full-text